LymphedemaV1, Main, Exploration, bibRecord, 004C29

Preventive chemotherapy in human helminthiasis: theoretical and operational aspects

Identifieur interne : 004C29 ( Main/Exploration ); précédent : 004C28; suivant : 004C30

Preventive chemotherapy in human helminthiasis: theoretical and operational aspects

Auteurs : A.-F. Gabrielli ; A. Montresor ; L. Chitsulo ; D. Engels ; L. Savioli

Source :

Transactions of the Royal Society of Tropical Medicine and Hygiene [ 0035-9203 ] ; 2011.

RBID : PMC:5576527

Descripteurs français

KwdFr :
- Analyse coût-bénéfice, Animaux, Antihelminthiques (usage thérapeutique), Facteurs de risque, Femelle, Filariose lymphatique (), Filariose lymphatique (traitement médicamenteux), Filariose lymphatique (épidémiologie), Helminthiase (), Helminthiase (traitement médicamenteux), Helminthiase (épidémiologie), Humains, Mâle, Onchocercose (), Onchocercose (traitement médicamenteux), Onchocercose (épidémiologie), Santé publique, Schistosomiase (), Schistosomiase (traitement médicamenteux), Schistosomiase (épidémiologie), Sol (parasitologie), Sélection de patients.
MESH :
- parasitologie : Sol.
- traitement médicamenteux : Filariose lymphatique, Helminthiase, Onchocercose, Schistosomiase.
- usage thérapeutique : Antihelminthiques.
- épidémiologie : Filariose lymphatique, Helminthiase, Onchocercose, Schistosomiase.
- Analyse coût-bénéfice, Animaux, Facteurs de risque, Femelle, Filariose lymphatique, Helminthiase, Humains, Mâle, Onchocercose, Santé publique, Schistosomiase, Sélection de patients.

English descriptors

KwdEn :
- Animals, Anthelmintics (therapeutic use), Cost-Benefit Analysis, Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (epidemiology), Elephantiasis, Filarial (prevention & control), Female, Helminthiasis (drug therapy), Helminthiasis (epidemiology), Helminthiasis (prevention & control), Humans, Male, Onchocerciasis (drug therapy), Onchocerciasis (epidemiology), Onchocerciasis (prevention & control), Patient Selection, Public Health, Risk Factors, Schistosomiasis (drug therapy), Schistosomiasis (epidemiology), Schistosomiasis (prevention & control), Soil (parasitology).
MESH :
- chemical , parasitology : Soil.
- chemical , therapeutic use : Anthelmintics.
- drug therapy : Elephantiasis, Filarial, Helminthiasis, Onchocerciasis, Schistosomiasis.
- epidemiology : Elephantiasis, Filarial, Helminthiasis, Onchocerciasis, Schistosomiasis.
- prevention & control : Elephantiasis, Filarial, Helminthiasis, Onchocerciasis, Schistosomiasis.
- Animals, Cost-Benefit Analysis, Female, Humans, Male, Patient Selection, Public Health, Risk Factors.

Abstract

Preventive chemotherapy (PC), the large-scale distribution of anthelminthic drugs to population groups at risk, is the core intervention recommended by the WHO for reducing morbidity and transmission of the four main helminth infections, namely lymphatic filariasis, onchocerciasis, schistosomiasis and soil-transmitted helminthiasis. The strategy is widely implemented worldwide but its general theoretical foundations have not been described so far in a comprehensive and cohesive manner. Starting from the information available on the biological and epidemiological characteristics of helminth infections, as well as from the experience generated by disease control and elimination interventions across the world, we extrapolate the fundamentals and synthesise the principles that regulate PC and justify its implementation as a sound and essential public health intervention. The outline of the theoretical aspects of PC contributes to a thorough understanding of the different facets of this strategy and helps comprehend opportunities and limits of control and elimination interventions directed against helminth infections.

Url:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576527

DOI: 10.1016/j.trstmh.2011.08.013
PubMed: 22040463
PubMed Central: 5576527

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Preventive chemotherapy in human helminthiasis: theoretical and operational aspects</title>
<author><name sortKey="Gabrielli, A F" sort="Gabrielli, A F" uniqKey="Gabrielli A" first="A.-F." last="Gabrielli">A.-F. Gabrielli</name>
</author>
<author><name sortKey="Montresor, A" sort="Montresor, A" uniqKey="Montresor A" first="A." last="Montresor">A. Montresor</name>
</author>
<author><name sortKey="Chitsulo, L" sort="Chitsulo, L" uniqKey="Chitsulo L" first="L." last="Chitsulo">L. Chitsulo</name>
</author>
<author><name sortKey="Engels, D" sort="Engels, D" uniqKey="Engels D" first="D." last="Engels">D. Engels</name>
</author>
<author><name sortKey="Savioli, L" sort="Savioli, L" uniqKey="Savioli L" first="L." last="Savioli">L. Savioli</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">22040463</idno>
<idno type="pmc">5576527</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576527</idno>
<idno type="RBID">PMC:5576527</idno>
<idno type="doi">10.1016/j.trstmh.2011.08.013</idno>
<date when="2011">2011</date>
<idno type="wicri:Area/Pmc/Corpus">003673</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003673</idno>
<idno type="wicri:Area/Pmc/Curation">003672</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">003672</idno>
<idno type="wicri:Area/Pmc/Checkpoint">002D93</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">002D93</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="wicri:Area/PubMed/Corpus">002409</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002409</idno>
<idno type="wicri:Area/PubMed/Curation">002409</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002409</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002409</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002409</idno>
<idno type="wicri:Area/Ncbi/Merge">004779</idno>
<idno type="wicri:Area/Ncbi/Curation">004779</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004779</idno>
<idno type="wicri:doubleKey">0035-9203:2011:Gabrielli A:preventive:chemotherapy:in</idno>
<idno type="wicri:Area/Main/Merge">004C62</idno>
<idno type="wicri:Area/Main/Curation">004C29</idno>
<idno type="wicri:Area/Main/Exploration">004C29</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Preventive chemotherapy in human helminthiasis: theoretical and operational aspects</title>
<author><name sortKey="Gabrielli, A F" sort="Gabrielli, A F" uniqKey="Gabrielli A" first="A.-F." last="Gabrielli">A.-F. Gabrielli</name>
</author>
<author><name sortKey="Montresor, A" sort="Montresor, A" uniqKey="Montresor A" first="A." last="Montresor">A. Montresor</name>
</author>
<author><name sortKey="Chitsulo, L" sort="Chitsulo, L" uniqKey="Chitsulo L" first="L." last="Chitsulo">L. Chitsulo</name>
</author>
<author><name sortKey="Engels, D" sort="Engels, D" uniqKey="Engels D" first="D." last="Engels">D. Engels</name>
</author>
<author><name sortKey="Savioli, L" sort="Savioli, L" uniqKey="Savioli L" first="L." last="Savioli">L. Savioli</name>
</author>
</analytic>
<series><title level="j">Transactions of the Royal Society of Tropical Medicine and Hygiene</title>
<idno type="ISSN">0035-9203</idno>
<idno type="eISSN">1878-3503</idno>
<imprint><date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Anthelmintics (therapeutic use)</term>
<term>Cost-Benefit Analysis</term>
<term>Elephantiasis, Filarial (drug therapy)</term>
<term>Elephantiasis, Filarial (epidemiology)</term>
<term>Elephantiasis, Filarial (prevention & control)</term>
<term>Female</term>
<term>Helminthiasis (drug therapy)</term>
<term>Helminthiasis (epidemiology)</term>
<term>Helminthiasis (prevention & control)</term>
<term>Humans</term>
<term>Male</term>
<term>Onchocerciasis (drug therapy)</term>
<term>Onchocerciasis (epidemiology)</term>
<term>Onchocerciasis (prevention & control)</term>
<term>Patient Selection</term>
<term>Public Health</term>
<term>Risk Factors</term>
<term>Schistosomiasis (drug therapy)</term>
<term>Schistosomiasis (epidemiology)</term>
<term>Schistosomiasis (prevention & control)</term>
<term>Soil (parasitology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Analyse coût-bénéfice</term>
<term>Animaux</term>
<term>Antihelminthiques (usage thérapeutique)</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Filariose lymphatique ()</term>
<term>Filariose lymphatique (traitement médicamenteux)</term>
<term>Filariose lymphatique (épidémiologie)</term>
<term>Helminthiase ()</term>
<term>Helminthiase (traitement médicamenteux)</term>
<term>Helminthiase (épidémiologie)</term>
<term>Humains</term>
<term>Mâle</term>
<term>Onchocercose ()</term>
<term>Onchocercose (traitement médicamenteux)</term>
<term>Onchocercose (épidémiologie)</term>
<term>Santé publique</term>
<term>Schistosomiase ()</term>
<term>Schistosomiase (traitement médicamenteux)</term>
<term>Schistosomiase (épidémiologie)</term>
<term>Sol (parasitologie)</term>
<term>Sélection de patients</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="parasitology" xml:lang="en"><term>Soil</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anthelmintics</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Helminthiasis</term>
<term>Onchocerciasis</term>
<term>Schistosomiasis</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Helminthiasis</term>
<term>Onchocerciasis</term>
<term>Schistosomiasis</term>
</keywords>
<keywords scheme="MESH" qualifier="parasitologie" xml:lang="fr"><term>Sol</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Helminthiasis</term>
<term>Onchocerciasis</term>
<term>Schistosomiasis</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term>
<term>Helminthiase</term>
<term>Onchocercose</term>
<term>Schistosomiase</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antihelminthiques</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Filariose lymphatique</term>
<term>Helminthiase</term>
<term>Onchocercose</term>
<term>Schistosomiase</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Cost-Benefit Analysis</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Patient Selection</term>
<term>Public Health</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Analyse coût-bénéfice</term>
<term>Animaux</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Filariose lymphatique</term>
<term>Helminthiase</term>
<term>Humains</term>
<term>Mâle</term>
<term>Onchocercose</term>
<term>Santé publique</term>
<term>Schistosomiase</term>
<term>Sélection de patients</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p id="P1">Preventive chemotherapy (PC), the large-scale distribution of anthelminthic drugs to population groups at risk, is the core intervention recommended by the WHO for reducing morbidity and transmission of the four main helminth infections, namely lymphatic filariasis, onchocerciasis, schistosomiasis and soil-transmitted helminthiasis. The strategy is widely implemented worldwide but its general theoretical foundations have not been described so far in a comprehensive and cohesive manner. Starting from the information available on the biological and epidemiological characteristics of helminth infections, as well as from the experience generated by disease control and elimination interventions across the world, we extrapolate the fundamentals and synthesise the principles that regulate PC and justify its implementation as a sound and essential public health intervention. The outline of the theoretical aspects of PC contributes to a thorough understanding of the different facets of this strategy and helps comprehend opportunities and limits of control and elimination interventions directed against helminth infections.</p>
</div>
</front>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Chitsulo, L" sort="Chitsulo, L" uniqKey="Chitsulo L" first="L." last="Chitsulo">L. Chitsulo</name>
<name sortKey="Engels, D" sort="Engels, D" uniqKey="Engels D" first="D." last="Engels">D. Engels</name>
<name sortKey="Gabrielli, A F" sort="Gabrielli, A F" uniqKey="Gabrielli A" first="A.-F." last="Gabrielli">A.-F. Gabrielli</name>
<name sortKey="Montresor, A" sort="Montresor, A" uniqKey="Montresor A" first="A." last="Montresor">A. Montresor</name>
<name sortKey="Savioli, L" sort="Savioli, L" uniqKey="Savioli L" first="L." last="Savioli">L. Savioli</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004C29 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004C29 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     PMC:5576527
   |texte=   Preventive chemotherapy in human helminthiasis: theoretical and operational aspects
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:22040463" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

Serveur d'exploration sur le lymphœdème

Preventive chemotherapy in human helminthiasis: theoretical and operational aspects

Preventive chemotherapy in human helminthiasis: theoretical and operational aspects

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.